Literature DB >> 17721406

Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography.

Ron B Mitchell1.   

Abstract

OBJECTIVE: To evaluate the outcome of adenotonsillectomy for obstructive sleep apnea (OSA) in children using objective data from polysomnography supplemented by subjective proxy reports from the OSA-18 quality of life instrument. STUDY
DESIGN: Prospective cohort study.
METHODS: Children 3 to 14 years of age with OSA diagnosed principally on the basis of polysomnography as having an obstructive apnea/hypopnea index (AHI) of 5 or greater underwent adenotonsillectomy. OSA was classified as mild (AHI > or = 5 < 10), moderate (AHI > or = 10 < 20), or severe (AHI > or =20). Children enrolled in the study also had postoperative polysomnography 3 to 6 months after surgery. Caregivers completed the OSA-18 survey before surgery and within 6 months after surgery. Pearson correlation was used to compare the pre- and postoperative AHI values with the pre- and postoperative OSA-18 total scores. SAS procedures (SAS Corp., Cary, NC) were used for statistical analyses. A P value less than or equal to .05 was considered significant.
RESULTS: The study population included 79 healthy children, 40 of who were male. The mean age was 6.3 (range, 3.0-14.0) years. Only tonsillar size was correlated significantly with a high preoperative AHI. For all children, the preoperative AHI value was higher than the postoperative value. The mean preoperative AHI for the study population was 27.5, whereas the mean postoperative AHI was 3.5. This change was highly significant (P < .001). The percentage of children with normal polysomnography parameters after adenotonsillectomy ranged from 71% to 90% as a function of the criteria used to define OSA. It was highest when an obstructive apnea index less than 1 was used and lowest when an AHI less than 1 was used to define resolution of OSA. Overnight respiratory parameters after adenotonsillectomy were normal for all children with mild OSA. Three (12%) children with moderate preoperative OSA, and 13 (36%) children with severe preoperative OSA had persistent OSA after adenotonsillectomy. Resolution of OSA occurred in all children with a preoperative AHI less than or equal to 10 and in 73% of children with a preoperative AHI greater than 10. The mean total OSA-18 score and the mean scores for all domains showed significant improvement after surgery (P < .001). The preoperative AHI values had a fair correlation with the preoperative total OSA-18 scores (r = 0.28), but postoperative AHI values had a poor correlation with the postoperative total OSA-18 scores (r = 0.16). Caregivers reported snoring some, most, or all of the time in 22 (28%) children; this group included all children with persistent OSA.
CONCLUSIONS: Adenotonsillectomy for OSA results in a dramatic improvement in respiratory parameters as measured by polysomnography in the majority of healthy children. Quality of life also improves significantly after adenotonsillectomy for OSA in children. However, the correlation between improvements in respiratory parameters and improvements in quality of life is poor. Severe preoperative OSA is associated with persistence of OSA after adenotonsillectomy. Postoperative reports of symptoms such as snoring and witnessed apneas correlate well with persistence of OSA after adenotonsillectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17721406     DOI: 10.1097/MLG.0b013e318123ee56

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  52 in total

1.  Characteristics and surgical and clinical outcomes of severely obese children with obstructive sleep apnea.

Authors:  Gulnur Com; John L Carroll; Xinyu Tang; Maria S Melguizo; Charles Bower; Supriya Jambhekar
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

2.  Polysomnography should not be required both before and after adenotonsillectomy for childhood sleep disordered breathing.

Authors:  Norman R Friedman
Journal:  J Clin Sleep Med       Date:  2007-12-15       Impact factor: 4.062

3.  Adenopharyngoplasty vs Adenotonsillectomy in Children With Severe Obstructive Sleep Apnea: A Randomized Clinical Trial.

Authors:  Johan Fehrm; Pia Nerfeldt; Joar Sundman; Danielle Friberg
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

4.  Continuous positive airway pressure for obstructive sleep apnea in children.

Authors:  Jessie J Wang; Toshihiro Imamura; James Lee; Marie Wright; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

Review 5.  Clinical practice: diagnosis and treatment of childhood snoring.

Authors:  Ioannis M Vlastos; John K Hajiioannou
Journal:  Eur J Pediatr       Date:  2009-07-21       Impact factor: 3.183

6.  Tonsillectomy in children.

Authors:  Boris A Stuck; Karl Götte; Jochen P Windfuhr; Harald Genzwürker; Horst Schroten; Tobias Tenenbaum
Journal:  Dtsch Arztebl Int       Date:  2008-12-05       Impact factor: 5.594

7.  Antiinflammatory therapy outcomes for mild OSA in children.

Authors:  Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Hari P R Bandla; David Gozal
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

Review 8.  Treatment alternatives for sleep-disordered breathing in the pediatric population.

Authors:  Ann C Halbower; Brian M McGinley; Philip L Smith
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

9.  The burden of obstructive sleep apnea in pediatric sickle cell disease: a Kids' inpatient database study.

Authors:  Po-Yang Tsou; Christopher M Cielo; Melissa S Xanthopoulos; Yu-Hsun Wang; Pei-Lun Kuo; Ignacio E Tapia
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

10.  Psychosocial Characteristics of Children with Central Disorders of Hypersomnolence Versus Matched Healthy Children.

Authors:  Kristin T Avis; Jiabin Shen; Patrick Weaver; David C Schwebel
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.